Clinical Trials Browser

Phase 2 × Advanced Solid Tumor × 90 days × Clear all

NCT04886271 2026-04-15

Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors

Phase 2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT04083976 2026-03-19

RAGNAR

Phase 2 Active not recruiting

316 enrolled 15 charts

Other solid neoplasm

Advanced Solid Tumor